FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Case insensitive SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Enasidenib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tafasitamab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tafasitamab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tafasitamab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tafasitamab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide 40 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Exemestane-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Exemestane only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Exemestane only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Exemestane 25 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Exemestane-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erdafitinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erdafitinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Etoglucid only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Etoglucid-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide 1 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide 2 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide 3 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide 4 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pomalidomide-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Picoplatin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Picoplatin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Plevitrexed only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Plevitrexed-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Moxetumomab pasudotox-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Moxetumomab pasudotox only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Testolactone only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Testolactone only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Testolactone 50 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Testolactone-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Testolactone-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tasonermin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tasonermin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Zanolimumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Zanolimumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belantamab mafodotin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belantamab mafodotin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belantamab mafodotin-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belantamab mafodotin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 160 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Razoxane-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Razoxane only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Razoxane only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Razoxane 125 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Razoxane-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Oregovomab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Oregovomab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nafoxidine-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nafoxidine only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naptumomab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naptumomab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilutamide only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilutamide only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilutamide 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilutamide-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nilutamide-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Obinutuzumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Obinutuzumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Obinutuzumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Obinutuzumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Abemaciclib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Abemaciclib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Abemaciclib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Abemaciclib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Acalabrutinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Acalabrutinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Acalabrutinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Acalabrutinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alitretinoin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alitretinoin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Altretamine-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Altretamine only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Altretamine 50 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Altretamine-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Altretamine only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belinostat-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belinostat only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belinostat 500 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belinostat-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Belinostat only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib (as bosutinib monohydrate) 100 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Bosutinib (as bosutinib monohydrate) 500 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Bosutinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 11 of 16 Next End

Reference Sets

Qualifier value foundation reference set

Back to Start